粵水電(002060.SZ):簽訂約3.38億元共青河(馬鹿至澳內段)興水惠農工程施工合同
格隆匯12月16日丨粵水電(002060.SZ)公佈,近日,公司與茂名市浩天科技有限公司(簡稱“項目業主”或“茂名浩天科技”)簽訂《共青河(馬鹿至澳內段)興水惠農工程施工合同》(合同編號:HTKJ-2022016)。合同金額約3.38億元。
該項目位於茂名高新區、電白區及水東灣新城境內,工程設計線路全長19.845km,擬新建排水壓力管道長3073m,改造渠道長10872m,新建卧地渡槽2200m,新建箱涵長3700m,拆除重建(改建)機耕橋25座,新建節制閘7座,拆除重建放水涵4座,拆除重建泄洪閘1座,拆除重建過底涵1座,新建箱涵1座。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.